Abstract:Abstract Background Dysregulation of fibroblast growth factor receptor (FGFR ) signaling pathway has been observed in head and neck squamous cell carcinoma (HNSCC) and is a promising therapeutic target for selective tyrosine kinase inhibitors (TKIs). Potential predictive biomarkers for response to FGFR-targeted therapies are urgently needed. Understanding the epigenetic regulation of FGF pathway related genes, i.e. FGFRs, FGFs, and CCND1 , could enlighten the way towards biomarker-selected FGFR-targeted therapies. Methods We performed DNA methylation analysis of the encoding genes FGFR1, FGFR2 , FGFR3, FGFR4, FGF1-14 , FGF16-23 , and CCND1 at single CpG site resolution (840 CpG sites) employing The Cancer Genome Research Atlas (TCGA) HNSCC cohort comprising N = 530 tumor tissue and N = 50 normal adjacent tissue samples. We correlated DNA methylation to mRNA expression with regard to human papilloma virus (HPV) and gene amplification status. Moreover, we investigated the correlation of methylation with sensitivity to the selective FGFR inhibitors PD 173074 and AZD4547 in N = 40 HPV(−) HNSCC cell lines. Results We found sequence-contextually nuanced CpG methylation patterns in concordance with epigenetically regulated genes. High methylation levels were predominantly found in the promoter flank and gene body region, while low methylation levels were present in the central promoter region for most of the analyzed CpG sites. FGFRs, FGFs, and CCND1 methylation differed significantly between tumor and normal adjacent tissue and was associated with HPV and gene amplification status. CCND1 promoter methylation correlated with CCND1 amplification . For most of the analyzed CpG sites, methylation levels correlated to mRNA expression in tumor tissue. Furthermore, we found significant correlations of DNA methylation of specific CpG sites with response to the FGFR1/3–selective inhibitors PD 173074 and AZD4547, predominantly within the transcription start site of CCND1 . Conclusions Our results suggest an epigenetic regulation of CCND1 , FGFRs, and FGFs via DNA methylation in HNSCC and warrants further investigation of DNA methylation as a potential predictive biomarker for response to selective FGFR inhibitors in clinical trials.

Prognostic Potential of KLOTHO and SFRP1 Promoter Methylation in Head and Neck Squamous Cell Carcinoma

The Methylation Modification of M6a Regulators Contributes to the Prognosis of Head and Neck Squamous Cell Carcinoma

DNA Methylation-Mediated Klotho Silencing is an Independent Prognostic Biomarker of Head and Neck Squamous Carcinoma

Evaluation Of Promoter Hypermethylation Detection In Body Fluids As A Screening/Diagnosis Tool For Head And Neck Squamous Cell Carcinoma

Detection of Promoter Hypermethylation in Salivary Rinses As a Biomarker for Head and Neck Squamous Cell Carcinoma Surveillance.

Prognostic Gene Signature for Squamous Cell Carcinoma with a Higher Risk for Treatment Failure and Accelerated MEK-ERK Pathway Activity

Clinical Significance of Methylation of E-cadherin and P14arf Gene Promoters in Skin Squamous Cell Carcinoma Tissues.

An aberrant DNA methylation signature for predicting the prognosis of head and neck squamous cell carcinoma

Novel DNA methylation biomarkers for early diagnosis of oral tongue squamous cell carcinoma (OTSCC)

DNA Methylation as a Diagnostic, Prognostic, and Predictive Biomarker in Head and Neck Cancer

SP1 Gene Methylation in Head and Neck Squamous Cell Cancer in HPV-Negative Patients

Fibroblast growth factor (FGF), FGF receptor (FGFR), and cyclin D1 (CCND1) DNA methylation in head and neck squamous cell carcinomas is associated with transcriptional activity, gene amplification, human papillomavirus (HPV) status, and sensitivity to tyrosine kinase inhibitors

Diagnostic Role of Wnt Pathway Gene Promoter Methylation in Non Small Cell Lung Cancer.

Transcriptional Inactivation of Secreted Frizzled-Related Protein 1 by Promoter Hypermethylation As a Potential Biomarker for Non-Small Cell Lung Cancer.

Promoter DNA methylation patterns in oral, laryngeal and oropharyngeal anatomical regions are associated with tumor differentiation, nodal involvement and survival

Role of DNA methylation-mediated Klotho gene silencing in the prognosis of head and neck squamous carcinoma

New Dna Methylation Markers and Global Dna Hypomethylation Are Associated with Oral Cancer Development

Analysis of methylation-driven genes for predicting the prognosis of patients with oral squamous cell carcinoma

Portrait of DNA methylated genes predictive of poor prognosis in head and neck cancer and the implication for targeted therapy

High RASSF1A promoter methylation levels are predictive of poor prognosis in fine-needle aspirate washings of breast cancer lesions

Abstract 6322: Dynamic, stage-course protein interaction network using high power CpG sites in head and neck squamous cell carcinoma